In particular, diabetes is one of the recognized risk factors associated with mortality triggered by COVID-19, and is strictly characterized by compromised immunity because of the accumulation of activated innate immune cells in metabolic tissues that leads to the release of inflammatory IL-1β and TNFα, which promote systemic insulin resistance and β-cell damage. The gene discussed is IL1B; the disease is COVID-19.